Dimensional Fund Advisors LP lifted its holdings in Maximus, Inc. (NYSE:MMS – Free Report) by 7.4% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,153,977 shares of the health services provider’s stock after acquiring an additional 79,092 shares during the period. Dimensional Fund Advisors LP owned 1.90% of Maximus worth $98,904,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Inspire Advisors LLC boosted its stake in Maximus by 1.4% in the 2nd quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider’s stock worth $751,000 after purchasing an additional 121 shares during the period. Wealth Enhancement Advisory Services LLC boosted its position in shares of Maximus by 4.5% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock worth $272,000 after acquiring an additional 136 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its stake in Maximus by 2.4% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 6,479 shares of the health services provider’s stock valued at $544,000 after acquiring an additional 149 shares in the last quarter. Verdence Capital Advisors LLC increased its holdings in Maximus by 3.7% in the 1st quarter. Verdence Capital Advisors LLC now owns 4,730 shares of the health services provider’s stock valued at $397,000 after acquiring an additional 167 shares during the last quarter. Finally, Bridge City Capital LLC lifted its stake in Maximus by 0.8% in the 1st quarter. Bridge City Capital LLC now owns 24,182 shares of the health services provider’s stock worth $2,029,000 after purchasing an additional 188 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.
Maximus Trading Up 1.3 %
Shares of Maximus stock opened at $91.77 on Wednesday. Maximus, Inc. has a twelve month low of $72.39 and a twelve month high of $93.97. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.61. The business has a 50-day moving average price of $89.82 and a 200-day moving average price of $86.23. The firm has a market cap of $5.58 billion, a price-to-earnings ratio of 24.09 and a beta of 0.76.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were given a dividend of $0.30 per share. The ex-dividend date was Thursday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.31%. Maximus’s dividend payout ratio (DPR) is currently 31.50%.
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
- Five stocks we like better than Maximus
- Using the MarketBeat Stock Split Calculator
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is the Australian Securities Exchange (ASX)
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- The How And Why of Investing in Oil Stocks
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.